Home  /   Products  /   Anti-cold  /   Xylometazoline, dexpanthenol (Rinostop Double help) nasal spray 0.1 mg/5 mg/dose – [15 ml vial]
Xylometazoline, dexpanthenol (Rinostop Double help) nasal spray 0.1 mg/5 mg/dose - [15 ml vial]

Xylometazoline, dexpanthenol (Rinostop Double help) nasal spray 0.1 mg/5 mg/dose – [15 ml vial]

$13.66

Vasoconstrictor drug for local use in ent practice

SKU: 62715 Category:

Description

Rhinostop Dual Help Pharmacodynamics
Xylometazoline belongs to a group of local vasoconstrictors (decongestants) with alpha-adrenomimetic activity, causes narrowing of blood vessels of nasal mucosa, reduces hyperemia and edema of mucosa, restores nasal passageways patency, facilitates nasal breathing and thereby reduces symptoms of rhinitis. The action of the drug usually comes within a few minutes after application and lasts up to 10 hours.
Dexpanthenol is a B vitamin – a derivative of pantothenic acid. Dexpanthenol converts in the body into pantothenic acid, which is part of coenzyme A, and is involved in acetylation processes, carbohydrate and fat metabolism, the synthesis of acetylcholine, corticosteroids, porphyrins, stimulates the regeneration of skin, mucous membranes, normalizes cell metabolism, accelerates mitosis and increases the strength of collagen fibers. It has a regenerating, metabolic and mild anti-inflammatory effect.

Indications
– Acute respiratory diseases with rhinitis symptoms;
– Acute allergic rhinitis;
– vasomotor rhinitis;
– sinusitis;
– Otitis media (as part of combined therapy to reduce nasopharyngeal mucosal edema);
– to facilitate rhinoscopy;
– for restoring the disturbed nasal breathing after surgical interventions in the nasal cavity.

Contraindications
Hypersensitivity to the components of the drug, arterial hypertension, tachycardia, marked atherosclerosis, hyperthyroidism, glaucoma, atrophic rhinitis, dry rhinitis, porphyria, prostatic hyperplasia, brain surgery (in anamnesis), concomitant use with monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants, pregnancy, breast-feeding, children under 6 years of age.
Caution
Diabetes mellitus, pheochromocytoma, diseases of the cardiovascular system (including coronary heart disease), hypersensitivity to the action of adrenergic drugs accompanied by insomnia, dizziness, arrhythmias, tremors, increased blood pressure.
If you have one or more of the above diseases and conditions, you should consult your doctor before starting this medicine.
Use during pregnancy and breastfeeding
The drug should not be used during pregnancy. The drug is contraindicated during breastfeeding.
Consult a physician before using if you are pregnant or if you suspect that you might be pregnant, or if you plan to become pregnant.

Dosage and administration

  • Intranasal.
  • For adults and children over 6 years of age.
  • When using the nasal spray, the bottle must be held upright.
  • Nasal passages should be cleaned before use.
  • During injection, it is necessary to inhale lightly through the nose. One injection into each nasal passage up to 3-4 times a day.
  • The duration of therapy is 5-7 days.
  • Do not use for more than 7 days. Duration of drug administration in children is determined after consultation with a physician.
  • Repeated use is possible only after a break of several days.
  • If after 5 days of treatment no improvement occurs or symptoms worsen or new symptoms appear, consult a doctor. Use the drug only according to the indications, the method of administration and in the doses specified in the instructions.

Related products